Real-world long-term outcomes and safety of avacopan for antineutrophil cytoplasmic antibody-associated vasculitis with advanced renal dysfunction: a multicenter cohort study (4U-AAV Study).
- DOI
- 10.1007/s10157-026-02936-4
- Published
- 2026 Aug 26
- Container
- Clinical and experimental nephrology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s10157-026-02936-4,
title = {Real-world long-term outcomes and safety of avacopan for antineutrophil cytoplasmic antibody-associated vasculitis with advanced renal dysfunction: a multicenter cohort study (4U-AAV Study).},
author = {Muta K and Torigoe K and Hasegawa E and Kitamura M and Fukuda A and Kikuchi M and Miyamoto T and Nakata T and Fukunaga N and Fujimoto S and Nishino T},
year = {2026},
journal = {Clinical and experimental nephrology},
doi = {10.1007/s10157-026-02936-4},
url = {https://doi.org/10.1007/s10157-026-02936-4}
}RIS
TY - JOUR TI - Real-world long-term outcomes and safety of avacopan for antineutrophil cytoplasmic antibody-associated vasculitis with advanced renal dysfunction: a multicenter cohort study (4U-AAV Study). AU - Muta K AU - Torigoe K AU - Hasegawa E AU - Kitamura M AU - Fukuda A AU - Kikuchi M AU - Miyamoto T AU - Nakata T AU - Fukunaga N AU - Fujimoto S AU - Nishino T PY - 2026 JO - Clinical and experimental nephrology DO - 10.1007/s10157-026-02936-4 UR - https://doi.org/10.1007/s10157-026-02936-4 ER -
APA
K, M., K, T., E, H., M, K., A, F., M, K., T, M., T, N., N, F., S, F., & T, N. (2026). Real-world long-term outcomes and safety of avacopan for antineutrophil cytoplasmic antibody-associated vasculitis with advanced renal dysfunction: a multicenter cohort study (4U-AAV Study).. Clinical and experimental nephrology. https://doi.org/10.1007/s10157-026-02936-4
Source records
- pubmed · retrieved 2026-09-26T07:08:39.186Z